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 Gelatinous drop-like corneal dystrophy (GDLD; OMIM
204870) is a rare autosomal recessive corneal dystrophy,
mostly reported in the Japanese population, with an estimated
prevalence of 1 in 33,000 [1]. Clinical manifestations usually
appear in the first decade of life with bilateral, axial, elevated,
mulberry-like gelatinous lesions, due to primary amyloid depo-
sition in the subepithelium and anterior stroma of the cornea.
The amyloid deposits in the cornea will progressively spread
laterally and deeply within the stroma, leading to a progres-
sive opacification of the cornea and resulting in severe visual
damage, photophobia, and foreign-body sensation. In the se-
vere cases, corneal transplantation is required for recovery of
corneal clarity and visual rehabilitation [2,3].
Conventional position cloning revealed that the gene re-
sponsible for most cases of GDLD was tumor-associated cal-
cium signal transducer 2 (TACSTD2, formerly Trop2, GA733-
1, and M1S1) located at 1p32 [4]. The TACSTD2 gene con-
sists of a single exon spanning about 1.8 kb of genomic DNA.
It codes for a protein of 323 amino acids, which is a mono-
meric cell surface glycoprotein expressed in the cornea,
multistratified epithelia, and trophoblasts and is found in most
carcinomas with high protein expression levels [4,5]. The
physiological function of TACSTD2 has not been exactly elu-
cidated, whereas it is hypothesized that protein may act as a
calcium signal transducer [5].
Four mutations causing GDLD have been found in the
TACSTD2 gene in Japanese patients: Q118X, Q207X, S170X,
and c.632delA [4]. All four mutations generate an early stop
codon and lead to synthesis of a truncated protein. Molecular
genetic analysis of patients from diverse ethnic backgrounds
showed both genetic and allelic heterogeneity for GDLD [6-
10].
In the present study we report the molecular genetic analy-
sis of TACSTD2 in two unrelated consanguineous families with
GDLD, in which two novel TACSTD2 mutations were identi-
fied. To our knowledge this is the first report of GDLD with
novel gene mutations found in families from the southern and
southeastern region of China.
METHODS
Subjects:  Two unrelated Chinese families with GDLD were
examined. Family 1, consisting of 13 living individuals, 7
males and 6 females, with age range from 16 to 72 years, had
only one member (patient V:1) affected by GDLD. Family 2
involved 24 living individuals, including 9 males and 15 fe-
males, with age range from 15 to 76 years, in which one of the
family members (patient V:1) affected by GDLD. All partici-
pants received a detailed clinical examination. The probands
and all available family members were enrolled in the study
(Figure 1A, Figure 2A). Diagnosis of GDLD was based on
characteristic clinical manifestations of the corneas in two
patients and was further confirmed by histopathologic exami-
nation of the corneal tissues from the patients who received
lamellar keratoplasty.
The study was approved by the institutional ethics com-
mittee of Sir Run Run Shaw Hospital. Informed consent was
obtained from the patients and their family members who par-
ticipated in this study.
Mutation Analysis:  Molecular genetic analyses were per-
formed in the two probands and unaffected family members:
members III:9, IV:1, and V:2 from family 1 and members IV:3
and IV:9 from family 2 (Figure 1A, Figure 2A). Fifty healthy
Chinese subjects were examined as controls. Genomic DNA
was extracted from peripheral blood by standard procedures
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988[11]. The single exon of the TACSTD2 gene was amplified
using three sets of primers to generate overlapping products,
which were screened for mutations by direct sequencing. The
primers used in this study were identical to those reported by
Akhtar et al. [12]. Their sequences are as follows: TACSTD2;
F1/R1, 5'-ACG TGT CCC ACC AAC AAG AT-3' / 5'-CAG
GTA ATA GAT GAG CGT GCG-3', TACSTD2; F2/R2, 5'-
GGA TGT GTC ACC CAA ATA CCA-3' / 5'-CTT GAG CAG
CAG ACA CTT GGA -3', and TACSTD2; F3/R3, 5'-CCT ACT
ACT TCG AGA GGG ACA -3' / 5'-CAG GAA GCG TGA
CTC ACT T-3'. The sizes of the amplified DNA fragments are
681 bp, 423 bp, and 382 bp, respectively.
Polymerase chain reaction (PCR) was carried out in a
volume of 50 µl mixture containing 1 µM of each primer, 0.5
U of Hotstar Taq polymerase (Qiagen, Hilden, Germany), 250
µM dNTP mixture, 5 µl of 10X PCR buffer with MgCl2, 10 µl
of 5X Q-solution (Qiagen), and approximately 100 ng of hu-
man genomic DNA. Thermal cycling was performed using a
GeneAmp PCR System 9700 (Applied Biosystems, Foster
City, CA) with the following program: 15 min at 95 °C, fol-
lowed by 32 cycles of 94 °C for 1 min, 60 °C for 1 min, and 72
°C for 1 min, with a final extension step at 72 °C for 7 min.
Amplified DNA was purified using the QIAquick PCR
purification kit (Qiagen) and sequenced according to the pro-
tocols accompanying the BigDye Terminator cycle sequenc-
ing kit (Applied Biosystems). An ABI Prism 377 Genetic
Analyser (Applied Biosystems) was used to collect and ana-
lyze the sequence data. DNA was bidirectionally sequenced.
RESULTS
Clinical findings:  Proband A (V:1 from family 1) was a 16-
year-old boy, born of a normal pregnancy to a consanguine-
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Figure 1. Novel TACSTD2 mutation in family 1.  A: In this pedigree of the study family, M represents the mutant allele and + indicates the
wild-type allele. The proband is marked by an arrow. In the family tree, squares indicate male and circles indicate female of the family
members. Slashes denote family members who were deceased, whereas heavy shading means the individual who was affected by GDLD.
Double lines represent consanguineous spouses. B: Sequence analysis of TACSTD2 gene near codon 28 detected in a healthy control. C: The
sequence from proband A shows a homozygous insertion mutation, c.84insG (arrow). D: Double-wave peaks are seen after codon 28 (arrow)
resulting from nonmatching of nucleotide sequence in two alleles of family member II:9.
989ous family in Zhejiang province in the southeastern region of
China. Beginning at the age of 7, he experienced a slowly
progressive vision loss accompanied with photophobia and
lacrimation of both eyes. His visual acuity was limited to hand
movement at 1 m in both eyes at the time of presentation.
Examination revealed bilateral diffuse corneal opacities with
multiple grayish-white nodular elevations located in the sub-
epithelial area (Figure 3). The corneal opacification was sym-
metric in both eyes. The patient had no significant systemic
diseases. Ophthalmic examination of his parents and sister did
not reveal any ocular abnormalities, and there were no known
similar familial ocular conditions according to the report from
other family members.
Proband B (V:1 from family 2) was a 15-year-old girl
from a consanguineous family in Yunan province in southern
China. She presented with the same symptoms as proband A.
Family history was negative. Corneal examination revealed
less numerous small gelatinous opacities in the subepithelial
area than proband A. The lesions were mainly in the central
cornea with no vascularization in both corneas, and the pe-
ripheral cornea and deeper layers of the cornea were unre-
markable. Best-corrected visual acuity was 10/60 OD and 20/
80 OS. Ophthalmic examination of his parents did not reveal
any ocular abnormalities.
Molecular Analysis:  Analysis of the sequence data from
proband A revealed a homozygous mutation, c.84insG in
TACSTD2 (Figure 1C), resulting in a frameshift after codon
28 and a predicted stop codon at nt280. This mutation was
confirmed by analysis of the reverse sequence data. Heterozy-
gous mutations were detected in unaffected family members
IV:1, III:9, and V:2. Double-wave peaks were seen after codon
28, resulting from nonmatching of nucleotide sequence in two
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Figure 2. Novel TACSTD2 mutation in family 2.  A: Pedigree of the study family. In the family tree, squares indicate male and circles indicate
female of the family members. Slashes denote family members who were deceased, whereas heavy shading means the individual who was
affected by GDLD. Double lines represent consanguineous spouses. The numbers in the symbol in generation II and IV designate the number
of siblings. B: Normal sequence of TACSTD2 gene near codon 160. C: The sequence from proband B shows a deletion of C, c.480delC
(arrow). D: Double-wave peaks are seen after codon160 (arrow) resulting from nonmatching of nucleotide sequence in two alleles of family
member IV:3.
990alleles (Figure 1D). No mutations were detected in healthy
controls (Figure 1B).
DNA analysis identified a homozygous mutation in
TACSTD2 at codon160 (Figure 2C) in proband B. The muta-
tion was a single-base deletion, c.480delC, resulting in a frame-
shift mutation and a predicted stop codon at nt526. This muta-
tion was confirmed by analysis of the reverse sequence data
and was heterozygous in her parent (Figure 2D). No muta-
tions were detected in healthy controls (Figure 2B).
DISCUSSION
 GDLD is a rare genetic corneal disease. Up to date, only one
patient with GDLD was reported from China, with compound
heterozygous mutation Q118X/Y184C [10]. Q118X is the most
frequent mutation found in Japanese GDLD patients [4]. The
previous Chinese GDLD case lived in northern China, whose
ethnic relationship with Japanese was unclear. Our cases are
from two unrelated consanguineous families in the southern
and southeastern regions of China, and the mutations are found
to be novel. Moreover, our patients have no ethnic relation-
ship with the Japanese.
Apart from the mutations reported in Japan previously,
molecular heterogeneity has also been observed in India, the
United States, Europe, Tunisia [7], Turkey [8], and Vietnam
[9]. The two novel mutations identified in this study demon-
strate further mutational heterogeneity. Studies of the genetic
basis of the corneal dystrophies have revealed that most re-
ported cases of gelatinous corneal dystrophy are caused by
amino acid substitutions within the TACSTD2 gene, and most
reported mutations have been missense and nonsense muta-
tions. The two novel mutations identified in our current study
are both homozygous frame-shift mutations, and the sites of
the mutations are unique. These consisted of two insertions/
deletions of a nucleotide, causing a shift in the translational
reading frame and introducing a premature termination codon
not far downstream of the mutation site. Similar mutations
that have been reported previously are c.653delA [8],
c.632delA, and c.520insC [4,13].
The 40 kDa TACSTD2 protein contains an epidermal
growth factor-like repeat, a thyroglobulin repeat, a transmem-
brane domain, and a phosphatidylinositol (PIP2)-binding site,
harboring phosphorylatable serine and threonine residues near
the COOH-terminus [4]. Mutation c.84insG in TACSTD2 re-
sults in a predicted stop codon at nt280. The effect of this
truncating mutation is loss of the thyroglobulin repeat, the
transmembrane domain, and the PIP2-binding site. Mutation
c.480delC is similar to c.653delA, c.632delA, and c.520insC,
which result in structural removal of the transmembrane do-
main and the PIP2-binding site from the COOH-terminus of
the protein.
At least 20 mutations of TACSTD2 gene have been found
thus far. Considerable phenotypic variation has been reported
[2,7]. The phenotype-genotype correlation is not clear. It still
needs to be determined if the mutational pattern is correlated
with the clinical course, or may be a prognostic indicator. As
in our study, both occurrences are of the typical mulberry type
according to the classification proposed in Japan [2], whereas
the clinical manifestation of proband A with mutation c.84insG
was more severe than proband B with mutation c.480delC.
Further investigation is needed to determine whether an ear-
lier stop codon generated by mutation c.84insG could influ-
ence phenotype severity. More cases are needed to analyze
the phenotype-genotype correlation.
The role of mutations in TACSTD2 in the pathogenesis of
GDLD is also not well understood. Protein expression analy-
sis revealed perinuclear aggregation of the mutated, truncated
protein, whereas the normal protein was distributed diffusely
in the cytoplasm with a homogenous or fine granular pattern
[4]. Further elucidation of the cellular and molecular aspects
of function may provide insight into pathogenesis.
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